A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiety in Healthy Subjects
Latest Information Update: 02 Aug 2017
At a glance
- Drugs JNJ-19567470 (Primary) ; Lorazepam
- Indications Anxiety disorders
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 02 Aug 2017 New trial record